We evaluated further the accuracy of the COBAS AMPLICOR (Roche) (CA) PCR-based system in detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens. Endocervical specimens collected for any indication for testing for C. trachomatis and N. gonorrhoeae among a university hospital health system population were included. Testing for C. trachomatis was done by two PCR methods, CA and manual microwell AMPLICOR (Roche) (MWA), and by culture; testing for N. gonorrhoeae was done by CA and culture. Discrepancy resolution was performed. Reproducibility testing and hands-on labor time measurements for CA were done. Among 654 C. trachomatis samples, the prevalence of true positivity was 9.2%, and among the 618 N. gonorrhoeae samples, the prevalence of true positivity was 4.4%. result was estimated to be at 7.5 min. The prevalence of inhibitory specimens was 3.5%, including two positive C. trachomatis samples which would have been missed otherwise. The direct cost of each clinical result with CA was estimated to be $9.09. Our methods include a diverse range of indications for testing among women, using endocervical swabbing samples, 2 M sucrose phosphate transport medium, and discrepancy resolution for comparison. Under our test conditions, the CA system is an accurate, rapid, and cost-and labor-efficient method for detection of C. trachomatis and N. gonorrhoeae.Diagnosis of infection through laboratory testing based on the identification of amplified nucleic acid specific to the causative agent has been rapidly integrated into clinical practice, particularly in female reproductive tract infections (2). These tests offer enhanced accuracy and a marked decrease in time to result compared to traditional methods. In general these tests are also labor saving. Broad-based screening for genital Chlamydia trachomatis and Neisseria gonorrhoeae infections in women has been recommended (3), as they are prevalent and often asymptomatic and are the major known causes of ectopic pregnancy and tubal factor infertility when not detected and treated. They are also the two known causes of the acute clinical syndromes of mucopurulent cervicitis and pelvic inflammatory disease. Thus, the availability of a largely automated amplified nucleic acid-based test to assay simultaneously for chlamydia and gonococcal infection from a single specimen is an important advance and deserves intensive study in different settings to assess its true value.In this study we evaluated the accuracy, reproducibility, labor requirements, and costs of the COBAS AMPLICOR CT/NG system (Roche Diagnostic Systems, Branchburg, N.J.) (CA) for the detection of C. trachomatis and N. gonorrhoeae infections in endocervical swab samples.
MATERIALS AND METHODSFemale patients for whom testing for endocervical C. trachomatis and N. gonorrhoeae infection was indicated, as determined by their practitioners, provided specimens for this study. These patients were seen in our emergency department, private and staff obstetric and gynecologic clinics, and inpati...